ASHP Ambulatory Care Conference and Summit Held in Dallas, March 3 – 4
New recommendations for transforming how pharmacists care for patients in ambulatory practice settings were discussed at a consensus conference held by the American Society of Health-System Pharmacists (ASHP) and the ASHP Research and Education Foundation at ASHP’s first Ambulatory Care Conference and Summit on March 3 and 4, 2014, in Dallas.
The consensus conference, part of the organizations’ Pharmacy Practice Model Initiative (PPMI), was accompanied by 10 hours of continuing education on hot topics and emerging issues in ambulatory care pharmacy practice. More than 400 practitioners attended the sold-out inaugural event.
During the summit, attendees emphasized the need for pharmacists to continue to interact directly with patients in the ambulatory setting and to assume greater responsibility and accountability for patient outcomes. The goal of the summit was to create a vision for forward-thinking pharmacy practice models that will ensure that pharmacists participate as universally available and full members of all ambulatory health care teams, responsible and accountable for patient and health-system outcomes.
Leaders in ambulatory care pharmacy practice, medicine and nursing – along with representatives of national pharmacy, patient safety, and nursing organizations – reached consensus on draft recommendations to advance patient care in ambulatory settings. The 25 recommendations are focused within the following practice domains:
- Defining ambulatory care pharmacy practice,
- Patient care delivery and integration,
- Sustainable business models, and
- Outcomes and evaluation.
“The outcomes of this conference and summit are critical to enhancing access to the patient-care services of pharmacists in clinics and other outpatient settings,” said ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP. There is a great need to have more pharmacists serving in primary and specialty care roles on the patient care team in all clinics and outpatient settings. This is one of the reasons why ASHP is advocating so strongly that pharmacists must be recognized as providers under Medicare Part B.”
“The success of this conference is a direct result of the tremendous support from our members, who articulated these forward-thinking recommendations,” said Gerald E. Meyer, Pharm.D., M.B.A., FASHP. “With the changes in health care and the growing emphasis on seamless transitions of care, this work is critical to advancing our members’ contributions to patient care.
The ASHP Foundation will be supporting efforts to advance the summit recommendations as part of its continuing support of PPMI. “The ASHP Foundation is committed to helping ASHP and its members make significant progress in PPMI and its goal to transform how pharmacists care for patients,” said ASHP Foundation CEO Stephen J. Allen, M.S., FASHP.
Additional information on the conference and summit – including the program, speakers, and the consensus panel – can be found at the meeting website.
Contributions to the ASHP Foundation by the following corporations supported this event: Amgen (at the Leadership Level); Apexus, Omnicell, and Teva (at the Platinum Level); and Cardinal Health Foundation (at the Gold Level).
Proceedings of the Summit portion of the event will be published in the American Journal of Health-System Pharmacy later this year.
ASHP is the national professional organization whose 40,000 members include pharmacists, pharmacy technicians, and student pharmacists who provide patient care services in hospitals, health systems, and ambulatory clinics. For 70 years, the Society has been on the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists help people make the best use of medicines, visit ASHP's website, www.ashp.org, or its consumer website, www.safemedication.com.
About the ASHP Research and Education Foundation
The ASHP Research and Education Foundation was established in 1968 by the American Society of Health-System Pharmacists (ASHP) as a nonprofit, tax-exempt organization. As the philanthropic arm of ASHP, our vision is that patient outcomes improve because of the leadership and clinical skills of pharmacists, as vital members of the health care team, accountable for safe and effective medication use. Our mission is to improve the health and well-being of patients in health systems through appropriate, safe and effective medication use.